Published in Medical Letter on the CDC and FDA, January 27th, 2002
The CDC did not estimate when the shortage of DTP might end. It has been in short supply since 2000, when two manufacturers quit making it, leaving Aventis Pasteur and GlaxoSmithKline as the only U.S. suppliers.
The shot is typically given to children in a series of five doses - beginning during the child's first six months and ending at age four to six.
During the shortage, the CDC said, doctors can defer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.